1.
Open Forum Infect Dis
; 9(7): ofac272, 2022 Jul.
Article
in English
| MEDLINE
| ID: mdl-35873285
ABSTRACT
The modified 2-tier testing algorithm (MTTT) for Lyme disease (LD) has been approved by the US Food and Drug Administration. In this study, we show that the MTTT detected 28% more cases of early infection compared with the standard 2-tier algorithm while retaining high specificity in a region with a high incidence of LD.
2.
Emerg Infect Dis
; 28(6): 1292-1294, 2022 06.
Article
in English
| MEDLINE
| ID: mdl-35608954
ABSTRACT
In July 2021, a PCR-confirmed case of locally acquired Babesia microti infection was reported in Atlantic Canada. Clinical features were consistent with babesiosis and resolved after treatment. In a region where Lyme disease and anaplasmosis are endemic, the occurrence of babesiosis emphasizes the need to enhance surveillance of tickborne infections.
